Abstract
NOD2 (nucleotide-binding oligomerization domain-2), a pattern recognition receptor, is involved in innate immune defense against pathogens, intestinal mucosal barrier integrity, gut microbiota composition, autophagy, immune homeostasis and inflammation. NOD2 mutations have been associated primarily with childhood diseases (Blau syndrome and sarcoidosis with early-onset, monogenic Crohn’s disease), but also with adult diseases (NOD2-associated autoinflammatory syndrome – NAID, also called Yao syndrome etc.). Intermediate forms between Blau syndrome and NAID have also been described. Blau’s disease and early-onset sarcoidosis are the familial and the sporadic forms respectively of a dominantly inherited rare monogenic autoinflammatory disease. Blau’s syndrome starts in early childhood, evolving with non-caseating granulomatous arthritis with prominent tenosynovitis, dermatitis with a “bronzed”, maculo-papular or scaly skin rash, and intermittent fever. Periodic fever, generalized lymphadenopathy, and granulomatous visceral involvement may be present. Therapy consists in systemic steroids, immunosuppressants and biologic drugs. In adults the NAID or Yao’s syndrome evolves with bouts of systemic inflammation with lower limbs swelling, tenosynovitis and non-erosive arthritis, fever and dermatitis. We discuss the differential diagnosis with other granulomatous diseases. Increased awareness is necessary regarding these rare diseases which may alter the quality of life or lead to disability, in order to improve their prognosis.
Highlights
Systemic autoinflammatory diseases (SAID) are a spectrum of clinically and genetically heterogeneous disorders, evolving with bouts of apparently unprovoked inflammation [1]
Some SAIDassociated genes are located in chromosome 16, such as the familial Mediterranean fever gene MEFV and the NOD2 gene
Blau’s syndrome (BS) and early-onset sarcoidosis (EOS) are the familial and the sporadic forms respectively of a dominantly inherited rare monogenic autoinflammatory disease [8]
Summary
Systemic autoinflammatory diseases (SAID) are a spectrum of clinically and genetically heterogeneous disorders, evolving with bouts of apparently unprovoked inflammation [1]. A Crohn’s disease clinical picture has been shown to be related from mevalonate kinase deficiency to NOD2-associated diseases and others. Certain gain-offunction NOD2 mutations have been associated with Crohn’s disease, including its early-onset variant.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
